Bodybuilders and athletes using anabolic-androgenic steroids (AAS) face specific cosmetic surgery considerations — hepatic function effects, altered healing, and condition-specific procedures (gynecomastia, body contouring). Korean clinics increasingly see this patient population. Honest disclosure of steroid use is essential for safe management. This guide covers the considerations.
Why steroid use matters for cosmetic surgery
- Liver function effects from oral steroids.
- Cardiovascular changes from prolonged use.
- Cholesterol and lipid effects.
- Wound healing alterations.
- Anesthesia metabolism changes.
- Body composition changes affecting procedures.
- Specific conditions (gynecomastia) requiring surgery.
Common AAS in bodybuilding context
- Testosterone esters (cypionate, enanthate, propionate).
- Nandrolone (deca-durabolin).
- Oxymetholone, oxandrolone, stanozolol (oral).
- Trenbolone.
- Methyltestosterone.
- SARMs (selective androgen receptor modulators).
- Growth hormone (sometimes combined).
Hepatic risks
Hepatocellular adenomas
- Benign liver tumors associated with anabolic steroids.
- Particularly oral 17α-alkylated agents.
- 4% transformation rate to hepatocellular carcinoma.
- Most common in bodybuilders with long-term oral use.
- May cause spontaneous rupture and bleeding.
Other hepatic effects
- Elevated liver enzymes.
- Cholestatic injury.
- Peliosis hepatis (blood-filled cavities).
- Affects coagulation factor synthesis.
- Affects medication metabolism.
Cardiovascular concerns
- Cardiac hypertrophy from prolonged use.
- Altered lipid profile (low HDL, high LDL).
- Hypertension.
- Increased thrombotic risk.
- Sudden cardiac events possible.
- Cardiac evaluation pre-major surgery.
Wound healing considerations
- Generally robust healing with testosterone.
- Possible scar quality differences.
- Increased keloid risk in some patients.
- Skin quality affected by prolonged use.
- Subcutaneous fat distribution altered.
Common cosmetic procedures bodybuilders pursue
Gynecomastia surgery
- Most common cosmetic procedure for AAS users.
- Caused by aromatization of testosterone to estrogen.
- Permanent if persistent breast tissue developed.
- Liposuction and gland excision.
- Can be combined with body contouring.
- Cost: ₩4,000,000–₩10,000,000.
Body contouring
- HD lipo-etching for muscular definition.
- VASER liposuction for natural contours.
- Skin tightening (RF or surgical).
- Combination procedures common.
- Body builder-specific aesthetic goals.
Hair transplant
- Steroid use accelerates androgenetic alopecia.
- FUE common procedure.
- Need to manage AAS continuation effect on transplanted hair.
- Finasteride may be problematic for AAS users.
Facial aesthetic procedures
- Same options as non-AAS users.
- Steroid history disclosure relevant.
- Conservative facial procedures generally tolerated.
- Long-term skin quality considerations.
Disclosure essential — and why
Why patients sometimes avoid disclosure
- Stigma around AAS use.
- Concern about clinic refusing care.
- Privacy worry.
- Embarrassment.
Why disclosure matters
- Anesthesia adjustments needed.
- Monitoring requirements differ.
- Liver function evaluation needed.
- Cardiovascular assessment relevant.
- Bleeding risk assessment.
- Drug interaction considerations.
- Outcome expectations adjustment.
Korean clinic confidentiality
- Medical confidentiality applies.
- Information stays within medical record.
- Not shared without consent.
- Disclosure protected by privacy law.
Pre-operative evaluation
- Liver function tests (ALT, AST, GGT, alkaline phosphatase).
- Liver imaging if long-term use (ultrasound at minimum).
- CBC including hematocrit.
- Coagulation panel.
- Lipid panel.
- Comprehensive metabolic panel.
- Cardiac evaluation (EKG, possible stress test).
- Hormonal panel for symptom-related concerns.
Perioperative AAS management
Continuation question
- Generally continue testosterone if therapeutic.
- Consider stopping oral 17α-alkylated agents pre-op.
- Coordinate with prescribing physician if relevant.
- Document use accurately.
Specific concerns
- Increased clotting risk on testosterone — DVT prophylaxis.
- Hematocrit elevation — phlebotomy if extreme.
- Liver function optimization.
- Blood pressure control.
The 2026 GLP-1 + AAS combination context
- GLP-1 weight loss (Wegovy, Mounjaro) increasingly common in bodybuilders.
- Combined with AAS to preserve muscle during weight loss.
- Multiple medication interactions.
- Cosmetic surgery considerations multiplicative.
- Comprehensive medical disclosure essential.
Procedure-specific considerations
Gynecomastia surgery
- Most common AAS-related procedure.
- Recurrence possible with continued use.
- Combined with aromatase inhibitor consideration.
- Aesthetic outcomes generally good.
- Cycle off pre-surgery sometimes recommended.
Body contouring
- Hematocrit elevation increases bleeding risk.
- Conservative volume per session.
- Compression garment fit affected by muscle bulk.
- Recovery timeline normal otherwise.
Major procedures
- Liver function critical.
- Cardiac evaluation thorough.
- DVT prophylaxis aggressive.
- Anesthesia adjustments.
- Recovery monitoring extended.
Recovery considerations
- Continue or hold AAS per medical advice.
- Avoid heavy training during initial healing.
- Resume training gradually (weeks).
- Watch for cardiac symptoms.
- Liver function monitoring if continuing.
What patients should know
- AAS use is a real medical factor, not just lifestyle.
- Disclosure protected and necessary for safety.
- Korean clinics generally non-judgmental about disclosed information.
- Pre-op evaluation more thorough.
- Procedures generally safe with proper preparation.
- Long-term monitoring continues.
For international AAS users
- Bring full medication and supplement list.
- Recent labs from home country.
- Disclose at consultation.
- Consider home-country evaluation pre-trip.
- Plan for ongoing care continuity.
The honest framing
Anabolic steroid use creates real medical considerations for cosmetic surgery — hepatic, cardiovascular, hematologic — but disclosure protected by medical confidentiality enables safe management. The patients who get good outcomes disclose accurately, undergo appropriate evaluation, accept that pre-op workup is more extensive than for non-users, and coordinate medication management with surgical timing. The patients who hide AAS use risk serious complications: undetected hepatic adenomas, cardiac events, bleeding complications, anesthesia issues. Korean clinics serving the bodybuilding population are professional and confidential — disclosure is the safer path.